-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Eating and drinking can become difficult when esophageal cancer causes obstruction, pain, or impaired swallowing. Treatment may further affect appetite, digestion, and the ability to maintain weight. Nutritional care should therefore be integrated with oncology, surgery, radiation, speech pathology, and dietetic support rather than introduced only when severe weight loss occurs.
The goal is to maintain strength, support treatment tolerance, and preserve quality of life. A suitable plan may combine modified meals, oral nutrition supplements, enteral tube feeding, and occasionally parenteral nutrition. The route and intensity of support depend on swallowing ability, treatment stage, nutritional status, and patient preferences.
Routine screening should include current and previous weight, recent changes in intake, symptoms such as nausea or early satiety, and the effect of eating on swallowing. Dietitians can also assess muscle mass, hydration, blood results, and the nutritional demands of surgery or chemoradiation.
Patients at increased risk include those with substantial weight loss, severe dysphagia, persistent vomiting, or difficulty meeting treatment requirements. In Australia, dietetic services are available through many public hospitals and private oncology practices. Patients in regional areas may also access specialist advice through telehealth, although equipment and local meal preparation can influence the practicality of recommendations.
Food texture, liquid thickness, meal size, and positioning should be selected after an individual swallowing assessment. A speech pathologist can identify safer consistencies and recommend strategies such as upright positioning, small bites, extra time, and reduced distractions. Thickened drinks should not be used automatically because inappropriate fluid thickness can reduce intake and hydration.
Meals should remain nutritionally meaningful even when they need to be softer, minced, or otherwise modified. Soups, smoothies, and fortified drinks are not automatically suitable for people with dysphagia, particularly when aspiration risk is high. Sudden changes in swallowing, choking, chest pain, or coughing during meals require prompt review.
When swallowing remains safe, frequent small meals can be easier than three large meals. Adding oils, butter, cheese, milk powder, or suitable commercial thickeners can increase energy and protein without increasing meal volume. Protein-rich foods such as eggs, fish, poultry, tofu, yoghurt, legumes, and fortified dairy alternatives can be adapted to the recommended texture.
Oral nutrition supplements may help patients who can drink safely but cannot eat enough to meet their needs. Products available in Australian pharmacies and supermarkets include milk-based drinks, yoghurt-based supplements, and savoury options. Selection should consider flavour, lactose, sugar, allergies, medication interactions, and swallowing safety. If intake remains inadequate, continuing to force meals can worsen fatigue and distress.
Nasogastric feeding can provide short-term support while swallowing is assessed or while treatment improves. For longer periods, gastrostomy or jejunostomy access may be considered, depending on gastric emptying, reflux, aspiration risk, and the likely duration of nutritional support. Placement decisions should involve the treating team because tubes require specific care and can still be dislodged or blocked.
Enteral nutrition generally uses the gastrointestinal tract and is preferred over intravenous feeding when feasible. Formula type, rate, fluid content, and monitoring must be individualised. Before and during treatment, the team should review hydration, bowel function, blood glucose, electrolytes, and weight. Refeeding risk is particularly relevant when intake has been very low.
Parenteral nutrition is reserved for situations in which the gastrointestinal tract cannot be used safely or effectively, such as complete obstruction or severe malabsorption. It requires specialist oversight because of infection, clotting, glucose, electrolyte, and fluid-management risks. In many cases, it serves as a temporary bridge while enteral support becomes possible.
Support should be adjusted when symptoms or treatment effects change. The following signs indicate that the current plan may no longer be adequate:
Australian patients may obtain nutrition products from community pharmacies and supermarkets, while prescribed formulas and feeding supplies are usually arranged through a hospital, home-care service, or specialist supplier. Major cancer centres in Sydney, Melbourne, Brisbane, and Perth commonly provide coordinated dietetic and allied-health services.
Practical options to discuss with the care team include:
Meal plans can also reflect Australia’s culturally diverse food preferences. Traditional foods may be adapted to a safe texture, and family members can help with shopping or preparation when fatigue limits independence. Where foods are unfamiliar to the clinical team, asking about customary ingredients and meal patterns often produces more workable advice.
Nutrition plans should be reviewed before surgery, during chemoradiation, at every major treatment transition, and when symptoms change. Clear documentation of swallowing restrictions, fluid consistency, supplement use, feeding route, and monitoring requirements helps prevent conflicting advice across services.
Support should also include symptom management. Pain relief, antiemetics, oral care, treatment of reflux, and management of taste changes can improve intake. Advance care discussions may be appropriate for people with progressive disease, ensuring that nutritional goals reflect comfort and personal priorities as well as clinical feasibility.
The practical takeaway is to record weight and intake at every review, seek early dietetic and swallowing assessment, and choose the least invasive feeding route that reliably meets nutritional needs while remaining safe.